Covaxin has become the only Covid-19 vaccine in the world to have studied and generated data from trials on kids as young as two years. Results of the trial showed seroconversion at 95-98% in children of all age groups, four weeks after they received their second dose.
from Times of India https://ift.tt/3FMKQH5
Friday, December 31, 2021
Tags
# IFTTT
# Times of India
![Author Image]()
About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment